Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin Expanded Access in Metastatic Colorectal Cancer
NCT02582970Phase 4Completed
- Sponsor
- Roche
- Start
- May 2005
- Primary completion
- Oct 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by Roche. Primary endpoint: Percentage of Participants With Adverse Events at 3 years. Started May 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02582970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02582970.